These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11496115)

  • 21. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.
    Hoffmann K; Löscher W
    Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants.
    Cox DS; Scott KR; Gao H; Raje S; Eddington ND
    J Pharm Sci; 2001 Oct; 90(10):1540-52. PubMed ID: 11745712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
    Baltes S; Gastens AM; Fedrowitz M; Potschka H; Kaever V; Löscher W
    Neuropharmacology; 2007 Feb; 52(2):333-46. PubMed ID: 17045309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
    Berger W; Hauptmann E; Elbling L; Vetterlein M; Kokoschka EM; Micksche M
    Int J Cancer; 1997 Mar; 71(1):108-15. PubMed ID: 9096673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Voskuyl RA; Redeker S; Aronica E; Wadman WJ; Gorter JA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):141-7. PubMed ID: 17392402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative in vivo microdialysis study on the influence of multidrug transporters on the blood-brain barrier passage of oxcarbazepine: concomitant use of hippocampal monoamines as pharmacodynamic markers for the anticonvulsant activity.
    Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y
    J Pharmacol Exp Ther; 2005 Aug; 314(2):725-31. PubMed ID: 15860570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.
    Cerveny L; Pavek P; Malakova J; Staud F; Fendrich Z
    Epilepsia; 2006 Mar; 47(3):461-8. PubMed ID: 16529607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study.
    Scism JL; Powers KM; Artru AA; Lewis L; Shen DD
    Brain Res; 2000 Nov; 884(1--2):77-86. PubMed ID: 11082489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.
    van Vliet EA; Zibell G; Pekcec A; Schlichtiger J; Edelbroek PM; Holtman L; Aronica E; Gorter JA; Potschka H
    Neuropharmacology; 2010 Feb; 58(2):404-12. PubMed ID: 19786037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport.
    Gibbs JP; Adeyeye MC; Yang Z; Shen DD
    Epilepsy Res; 2004 Jan; 58(1):53-66. PubMed ID: 15066675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches.
    Leandro K; Bicker J; Alves G; Falcão A; Fortuna A
    Pharmacol Res; 2019 Jun; 144():357-376. PubMed ID: 31051235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
    Bourasset F; Cisternino S; Temsamani J; Scherrmann JM
    J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.
    Löscher W; Potschka H
    J Pharmacol Exp Ther; 2002 Apr; 301(1):7-14. PubMed ID: 11907151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukotriene C4 secretion from normal murine mast cells by a probenecid-sensitive and multidrug resistance-associated protein-independent mechanism.
    Nguyen T; Gupta S
    J Immunol; 1997 May; 158(10):4916-20. PubMed ID: 9144509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy.
    Lazarowski A; Lubieniecki F; Camarero S; Pomata H; Bartuluchi M; Sevlever G; Taratuto AL
    Pediatr Neurol; 2004 Feb; 30(2):102-6. PubMed ID: 14984901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic administration of phenytoin induces efflux transporter overexpression in rats.
    Alvariza S; Fagiolino P; Vázquez M; Feria-Romero I; Orozco-Suárez S
    Pharmacol Rep; 2014 Dec; 66(6):946-51. PubMed ID: 25443719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
    Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S
    Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance in epilepsy: the role of the blood-brain barrier.
    Abbott NJ; Khan EU; Rollinson CM; Reichel A; Janigro D; Dombrowski SM; Dobbie MS; Begley DJ
    Novartis Found Symp; 2002; 243():38-47; discussion 47-53, 180-5. PubMed ID: 11990780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
    Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
    Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
    van der Sandt IC; Vos CM; Nabulsi L; Blom-Roosemalen MC; Voorwinden HH; de Boer AG; Breimer DD
    AIDS; 2001 Mar; 15(4):483-91. PubMed ID: 11242145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.